CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Potential protective mechanisms of green tea polyphenol EGCG against COVID-19 Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research Limitations of Repeat Revascularization as an Outcome Measure Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCI Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease

Original Research2019 Feb 12;139(7):863-873.

JOURNAL:Circulation. Article Link

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

Fanaroff AC, Clare R, Pieper KS et al. Keywords: cause of death; clinical trial; death; follow-up studies; quality control

FULL TEXT PDF